Evidence map›Paper›PMID 38174436›Full record

ArticleEpidemiology and infection2024

Rural-urban variation in COVID-19 vaccination uptake in Aotearoa New Zealand: Examining the national roll-out.

Talis Liepins, Gabrielle Davie, Rory Miller, Jesse Whitehead, Brandon De Graaf, Lynne Clay, Sue Crengle, Garry Nixon

Open access · goldAbstract read
In one paragraph

Article in Epidemiology and infection, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Talis LiepinsDepartment of General Practice and Rural Health, University of Otago, Dunedin, New Zealand.ORCID 0009-0006-0926-2578
Gabrielle DavieDepartment of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
Rory MillerDepartment of General Practice and Rural Health, University of Otago, Dunedin, New Zealand.
Jesse WhiteheadTe Ngira Institute for Population Research, University of Waikato, Hamilton, New Zealand.ORCID 0000-0001-9682-7544
Brandon De GraafDepartment of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand.
Lynne ClayDepartment of General Practice and Rural Health, University of Otago, Dunedin, New Zealand.
Sue CrengleNgāi Tahu Māori Health Research Unit, University of Otago, Dunedin, New Zealand.
Garry NixonDepartment of General Practice and Rural Health, University of Otago, Dunedin, New Zealand.
University of Otago · NZUniversity of Waikato · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to understand rural-urban differences in the uptake of COVID-19 vaccinations during the peak period of the national vaccination roll-out in Aotearoa New Zealand (NZ). Using a linked national dataset of health service users aged 12+ years and COVID-19 immunization records, age-standardized rates of vaccination uptake were calculated at fortnightly intervals, between June and December 2021, by rurality, ethnicity, and region. Rate ratios were calculated for each rurality category with the most urban areas (U1) used as the reference. Overall, rural vaccination rates lagged behind urban rates, despite early rapid rural uptake. By December 2021, a rural-urban gradient developed, with age-standardized coverage for R3 areas (most rural) at 77%, R2 81%, R1 83%, U2 85%, and U1 (most urban) 89%. Age-based assessments illustrate the rural-urban vaccination uptake gap was widest for those aged 12-44 years, with older people (65+) having broadly consistent levels of uptake regardless of rurality. Variations from national trends are observable by ethnicity. Early in the roll-out, Indigenous Māori residing in R3 areas had a higher uptake than Māori in U1, and Pacific peoples in R1 had a higher uptake than those in U1. The extent of differences in rural-urban vaccine uptake also varied by region.

Indexed as

COVID-19COVID-19 VaccinesVaccinationAdolescentAdultAgedChildHumansMiddle AgedNew ZealandRural PopulationUrban PopulationYoung AdultCOVID-19 VaccinesCOVID-19equityNew Zealandruralvaccination

Identifiers

PMID38174436
PMCPMC10789992
OpenAlexW4390586779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.